Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: A distinct entity?

Journal of Clinical Oncology

Volumn 16, Issue 6, 1998, Pages 2052-2059

  Leblond, Véronique ^a   Davi, Frédéric ^a   Charlotte, Frédéric ^a   Dorent, Richard ^a   Bitker, Marc Olivier ^a   Sutton, Laurent ^a   Gandjbakhch, Iradj ^a   Binet, Jacques Louis ^a   Raphael, Martine ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; LOMUSTINE; MELPHALAN; METHOTREXATE; MONOCLONAL ANTIBODY; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE; VIRUS ENVELOPE PROTEIN;

ADULT; ARTICLE; B CELL LYMPHOMA; CANCER SURVIVAL; CLINICAL ARTICLE; COMPARATIVE STUDY; EPSTEIN BARR VIRUS; FEMALE; GENOTYPE; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOBLAST; IMMUNOSUPPRESSIVE TREATMENT; IN SITU HYBRIDIZATION; KIDNEY TRANSPLANTATION; LARGE CELL LYMPHOMA; LIVER TRANSPLANTATION; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MALE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SOUTHERN BLOTTING; TREATMENT OUTCOME; VIRUS INFECTION;

EID: 0031749534     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.6.2052     Document Type: Article

References (42)

1. Penn I: Cancers after cyclosporine therapy. Transplant Proc 20:276-279, 1988 (suppl 1)
2. Penn I: Cancers complicating organ transplantation. N Engl J Med 323:1767-1769, 1990
3. Opelz G, Henderson R: Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 342:1514-1516, 1993
4. Cockfield SM, Preiksaitis JK, Jewell LD, et al: Post-transplant lymphoproliferative disorder in renal allograft recipients: Clinical experience and risk factor analysis in a single center. Transplantation 56:88-95, 1993
5. Zutter MM, Martin JP, Sale GE, et al: Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood 72:520-529, 1988
6. Cleary ML, Sklar J: Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomas. Lancet 2:489-493, 1984
7. Armitage JM, Kormos RL, Stuart RS, et al: Postransplant lymphoproliferative disease in thoracic organ transplant patients: Ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant 10:877-887, 1991
8. Randhawa PS, Yousem SA, Paradis IL, et al: The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heart-lung transplant recipients. Am J Clin Pathol 92:177-185, 1989
9. Polson RJ, Neuberger J, Forman D, et al: De novo malignancies after liver transplantation. Transplant Proc 20:94-97, 1988
10. Shapiro RS: Epstein-Barr virus-associated B-cell lymphoproliferative disorders in immunodeficiency: Meeting the challenge. J Clin Oncol 8:371-373, 1990
11. Leblond V, Sutton L, Dorent R, et al: Lymphoproliferative disorders after organ transplantation: A report of 24 cases in a single center. J Clin Oncol 13:961-968, 1995
12. Stephan JL, Le Deist F, Blanche S, et al: Treatment of central nervous system B lymphoproliferative syndrome by local infusion of a B cell-specific monoclonal antibody. Transplantation 54:246-249, 1992
13. Fischer A, Blanche S, Le Bidois J, et al: Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med 324:1451-1456, 1991
14. Elias L, Portlock CS, Rosenberg SA: Combination chemotherapy of diffuse histiocytic lymphoma with cyclophosphamide. Adriamycin, vincristine and prednisone (CHOP). Cancer 42:1705-1710, 1978
15. Velasquez WS, McLaughlin P, Tucker S, et al: ESHAP - An effective chemotherapy regimen in refractory and relapsing lymphoma: A 4-year follow-up study. J Clin Oncol 12:1169-1176, 1994
16. Oken MM: Standard treatment of multiple myeloma. Mayo Clin Proc 69:781-786, 1994
17. Klimo P, Connors JM: MOPP/ABV hybrid program. Combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease. J Clin Oncol 3:1174-1182, 1985
18. Durandy A, Emilie D, Peuchmaur M, et al: Role of IL-6 in promoting growth of human EBV-induced B-cell tumors in severe combined immunodeficient mice. J Immunol 52:5361-5367, 1994
19. Locker J, Nalesnik M: Molecular genetic analysis of lymphoid tumors arising after organ transplantation. Am J Pathol 135:977-987, 1989
20. Hsu SM, Raine L, Fanger H: Use of avidin biotin peroxidase complex (ABC) in immunoperoxidase technique: A comparison between ABC and unlabelled (PAP) procedures. J Histochem Cytochem 29:577-580, 1980
21. Cordell JL, Falini B, Erber WN: Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphate anti alkaline phosphatase (APAAP complex). J Histochem Cytochem 32:219-229, 1984
22. Barletta JM, Kingma DW, Ling Y, et al: Rapid in situ hybridization for the diagnosis of latent Epstein-Barr virus infection. Mol Cell Probes 7:105-109, 1993
23. Harris NI, Jaffe ES, Stein H, et al: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361-1392, 1994
24. Cleary ML, Nalesnik MA, Shearer WT, et al: Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. Blood 72:349-352, 1988
25. Young L, Alfieri C, Henessy K, et al: Expression of Epstein-Barr virus transformation associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 321:1080-1085, 1989
26. Knowles DM, Cesarman E, Chadburn A, et al: Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 85:552-565, 1995
27. List AF, Greco A, Vogler LB: Lymphoproliferative diseases in immunocompromised hosts; The role of Epstein-Barr virus. J Clin Oncol 5:1673-1689, 1987
28. Farrell PJ: Epstein-Barr virus immortalizing genes. Trends Microbiol 3:105-109, 1995
29. Rea D, Fourcade C, Leblond V, et al: Patterns of EBV latent and replicative gene expression in EBV B-cell lymphoproliferative disorders after organ transplantation. Transplantation 58:317-324, 1994
30. Rowe M, Young LS, Crocker J, et al: Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: Implications for the pathogenesis of EBV-positive lymphomas in man. J Exp Med 173:147-158, 1991
31. Garcia RC, Brown NA, Schreck R, et al: B-cell lymphoma in severe combined immunodeficiency not associated with Epstein-Barr virus. Cancer 60:2941-2947, 1987
32. Ho M, Jaffe R, Miller G, et al: The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 45:719-727, 1988
33. Case records of the Massachusetts General Hospital (case 4-1985). N Engl J Med 312:226-237, 1985
34. Ambinder RF, Mann RB: Epstein-Barr-encoded RNA in situ hybridization: diagnostic applications. Hum Pathol 25:602-605, 1994
35. Ambinder RF, Mann RB: Detection and characterization of Epstein-Barr virus in clinical specimens. Am J Pathol 145:239-252, 1994
36. Halmiton-Dutoit SJ, Delecluse HJ, Raphael M, et al: Detection of Epstein-Barr virus genomes in AIDS related lymphomas: Sensitivity and specificity of in situ hybridization compared with Southern blotting. J Clin Pathol 44:676-680, 1991
37. Katz BZ, Raab-Traub N, Miller G: Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases; J Infect Dis 160:589-597, 1989
38. Nalesnik MA, Jaffe R, Starzl TE, et al: The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 133:173-192, 1988
39. Hanto DW, Frizzera G, Galj-Peczalska, et al: Epstein-Barr virus, immunodeficiency, and B-cell lymphoproliferation. Transplantation 39:461-472, 1985
40. Waller EK, Ziemianska M, Bangs CD, et al: Characterization of posttransplam lymphomas that express T-cell-associated markers: Immunophenotypes, molecular genetics, cytogenetics, and heterotransplantation in severe combined immunodeficient mice. Blood 82:247-261, 1993
41. Hanson MN, Morrison VA, Peterson BA, et al: Posttransplant T-cell lymphoproliferative disorders. An aggressive, late complication of solid-organ transplantation. Blood 88:3626-3633, 1996
42. Levine AM: Acquired immunodeficiency syndrome-related lymphoma. Blood 80:8-20, 1992